Literature DB >> 11422428

Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis.

J Jensen1, M Krakauer, F Sellebjerg.   

Abstract

CD154 (CD40-ligand, gp39), expressed on activated T cells, is crucial in T cell-dependent immune responses and may be involved in the pathogenesis of multiple sclerosis (MS). We studied cerebro-spinal fluid and peripheral blood T cell expression of CD154 in MS by flow cytometry. Patients with secondary progressive MS (SPMS) had constitutive CD154 expression on CD4 and CD8 T cells in blood. Constitutive CD154 expression was not observed in patients with relapsing-remitting MS (RRMS) or clinically isolated syndromes (CIS) suggestive of demyelinating disease. After ex vivo activation CD154 was, however, expressed on a higher percentage of T cells from patients with CIS or RRMS than from healthy control subjects. These results suggest involvement of CD154 in the pathogenesis of MS, and the shift from a relapsing-remitting to a secondary progressive disease course may be associated with constitutive, systemic CD154 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422428     DOI: 10.1046/j.1468-1331.2001.00232.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

Review 1.  Self-tolerance in multiple sclerosis.

Authors:  R E Gonsette
Journal:  Acta Neurol Belg       Date:  2012-03-24       Impact factor: 2.396

Review 2.  The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Suzanne A B M Aarts; Tom T P Seijkens; Koos J F van Dorst; Christine D Dijkstra; Gijs Kooij; Esther Lutgens
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

3.  Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.

Authors:  Suzanne A B M Aarts; Tom T P Seijkens; Pascal J H Kusters; Susanne M A van der Pol; Barbara Zarzycka; Priscilla D A M Heijnen; Linda Beckers; Myrthe den Toom; Marion J J Gijbels; Louis Boon; Christian Weber; Helga E de Vries; Gerry A F Nicolaes; Christine D Dijkstra; Gijs Kooij; Esther Lutgens
Journal:  J Neuroinflammation       Date:  2017-05-12       Impact factor: 8.322

4.  Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis.

Authors:  Suzanne Abm Aarts; Tom Tp Seijkens; Pascal Jh Kusters; Claudia M van Tiel; Myrthe E Reiche; Myrthe den Toom; Linda Beckers; Cindy Paa van Roomen; Menno Pj de Winther; Gijs Kooij; Esther Lutgens
Journal:  J Pathol       Date:  2019-01-30       Impact factor: 7.996

Review 5.  Escape from X chromosome inactivation and female bias of autoimmune diseases.

Authors:  Mohammad Javad Mousavi; Mahdi Mahmoudi; Somayeh Ghotloo
Journal:  Mol Med       Date:  2020-12-09       Impact factor: 6.354

6.  Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.

Authors:  Camilo E Fadul; Yang Mao-Draayer; Kathleen A Ryan; Randolph J Noelle; Heather A Wishart; Jacqueline Y Channon; Isaac R Kasper; Brant Oliver; Daniel W Mielcarz; Lloyd H Kasper
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-15

7.  Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris.

Authors:  Alexandra Polakova; Leonie Kauter; Adina Ismagambetova; Dario Didona; Farzan Solimani; Kamran Ghoreschi; Michael Hertl; Christian Möbs; Christoph Hudemann
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

8.  Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

Authors:  Jeppe Romme Christensen; Lars Börnsen; Rikke Ratzer; Fredrik Piehl; Mohsen Khademi; Tomas Olsson; Per Soelberg Sørensen; Finn Sellebjerg
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming.

Authors:  Alfonso Martín-Fontecha; Dirk Baumjohann; Greta Guarda; Andrea Reboldi; Miroslav Hons; Antonio Lanzavecchia; Federica Sallusto
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307

Review 10.  The role of CD4 T cells in the pathogenesis of multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.